271 related articles for article (PubMed ID: 23540748)
21. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
[TBL] [Abstract][Full Text] [Related]
22. The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan.
Okura Y; Ozaki K; Tanaka H; Takenouchi T; Sato N; Minamino T
Circ J; 2019 Oct; 83(11):2191-2202. PubMed ID: 31534064
[TBL] [Abstract][Full Text] [Related]
23. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
Carver JR; Shapiro CL; Ng A; Jacobs L; Schwartz C; Virgo KS; Hagerty KL; Somerfield MR; Vaughn DJ;
J Clin Oncol; 2007 Sep; 25(25):3991-4008. PubMed ID: 17577017
[TBL] [Abstract][Full Text] [Related]
24. Radiation-Induced Cardiovascular Toxicities.
Badiyan SN; Puckett LL; Vlacich G; Schiffer W; Pedersen LN; Mitchell JD; Bergom C
Curr Treat Options Oncol; 2022 Oct; 23(10):1388-1404. PubMed ID: 36087234
[TBL] [Abstract][Full Text] [Related]
25. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.
Lancellotti P; Nkomo VT; Badano LP; Bergler-Klein J; Bogaert J; Davin L; Cosyns B; Coucke P; Dulgheru R; Edvardsen T; Gaemperli O; Galderisi M; Griffin B; Heidenreich PA; Nieman K; Plana JC; Port SC; Scherrer-Crosbie M; Schwartz RG; Sebag IA; Voigt JU; Wann S; Yang PC; ; ; ;
Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):721-40. PubMed ID: 23847385
[TBL] [Abstract][Full Text] [Related]
26. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
Truong J; Yan AT; Cramarossa G; Chan KK
Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
[TBL] [Abstract][Full Text] [Related]
29. Late effects of Hodgkin's disease and its treatment.
Ng AK; Mauch PM
Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
[TBL] [Abstract][Full Text] [Related]
30. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group.
Bardi E; Mulder RL; van Dalen EC; Bhatt NS; Ruble KA; Burgis J; Castellino SM; Constine LS; den Hoed CM; Green DM; Koot BGP; Levitt G; Szonyi L; Wallace WH; Skinner R; Hudson MM; Kremer LCM; Effinger KE; Bresters D
Cancer Treat Rev; 2021 Nov; 100():102296. PubMed ID: 34571378
[TBL] [Abstract][Full Text] [Related]
31. Cardiotoxicity and cancer therapy.
Vasiliadis I; Kolovou G; Mikhailidis DP
Angiology; 2014 May; 65(5):369-71. PubMed ID: 23921503
[No Abstract] [Full Text] [Related]
32. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
33. Pathology of radiation and anthracycline cardiotoxicity.
Berry GJ; Jorden M
Pediatr Blood Cancer; 2005 Jun; 44(7):630-7. PubMed ID: 15825155
[TBL] [Abstract][Full Text] [Related]
34. Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?
Pourier MS; Mavinkurve-Groothuis AM; Loonen J; Bökkerink JP; Roeleveld N; Beer G; Bellersen L; Kapusta L
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654133
[TBL] [Abstract][Full Text] [Related]
35. SEOM clinical guidelines on cardiovascular toxicity (2018).
Virizuela JA; García AM; de Las Peñas R; Santaballa A; Andrés R; Beato C; de la Cruz S; Gavilá J; González-Santiago S; Fernández TL
Clin Transl Oncol; 2019 Jan; 21(1):94-105. PubMed ID: 30627982
[TBL] [Abstract][Full Text] [Related]
36. Impact of treatment exposures on cardiovascular risk and insulin resistance in childhood cancer survivors.
Baker KS; Chow EJ; Goodman PJ; Leisenring WM; Dietz AC; Perkins JL; Chow L; Sinaiko A; Moran A; Petryk A; Steinberger J
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1954-63. PubMed ID: 24008489
[TBL] [Abstract][Full Text] [Related]
37. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics.
Parashar A; Hundley WG
Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282
[TBL] [Abstract][Full Text] [Related]
38. Short and long term radiation induced cardiovascular disease in patients with cancer.
Nielsen KM; Offersen BV; Nielsen HM; Vaage-Nilsen M; Yusuf SW
Clin Cardiol; 2017 Apr; 40(4):255-261. PubMed ID: 28139844
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Risk in Survivors of Cancer.
Zheng HC; Onderko L; Francis SA
Curr Cardiol Rep; 2017 Jul; 19(7):64. PubMed ID: 28550591
[TBL] [Abstract][Full Text] [Related]
40. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Lenneman CG; Sawyer DB
Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
